Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
- Author
- ZHANEL, George G1 2 ; LAWSON, Christopher D3 ; LYNCH, Joseph P8 ; KARLOWSKY, James A1 4 ; ADAM, Heather1 4 ; SCHWEIZER, Frank1 5 ; ZELENITSKY, Sheryl3 ; LAGACE-WIENS, Philippe R. S1 6 ; DENISUIK, Andrew1 ; RUBINSTEIN, Ethan1 2 ; GIN, Alfred S1 3 7 ; HOBAN, Daryl J1 4
[1] Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada
[2] Department of Medicine. Health Sciences Centre, Winnipeg, MB, Canada
[3] Faculty of Pharmacy, University of Manitoba, Winnipeg, MB, Canada
[4] Department of Clinical Microbiology, Health Sciences Centre, Winnipeg, MB, Canada
[5] Department of Chemistry, Faculty of Science, University of Manitoba, Winnipeg. MB, Canada
[6] Department of Clinical Microbiology, Saint-Boniface General Hospital, Winnipeg. MB, Canada
[7] Department of Pharmacy, Health Sciences Centre, Winnipeg, MB, Canada
[8] Division of Pulmonary, Critical Care. Allergy and Clinical Immunology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, United States - Source
Drugs (Basel). 2013, Vol 73, Num 2, pp 159-177, 19 p ; ref : 98 ref
- CODEN
- DRUGAY
- ISSN
- 0012-6667
- Scientific domain
- Pharmacology drugs
- Publisher
- Adis International, Auckland
- Publication country
- New Zealand
- Document type
- Article
- Language
- English
- Keyword (fr)
- Activité biologique Animal Antibactérien Antibiotique Article synthèse Association médicamenteuse Ceftazidime Chimie Dérivé de la céphalosporine Efficacité traitement Essai clinique Homme Indication Mécanisme action Pharmacocinétique Résistance traitement Toxicité Avibactam Inhibiteur des β-lactamases Enzyme Hydrolases Inhibiteur enzyme β-Lactamase β-Lactamines
- Keyword (en)
- Biological activity Animal Antibacterial agent Antibiotic Review Drug combination Ceftazidime Chemistry Cephalosporin derivatives Treatment efficiency Clinical trial Human Indication Mechanism of action Pharmacokinetics Treatment resistance Toxicity Avibactam β-Lactamases inhibitor Enzyme Hydrolases Enzyme inhibitor β-Lactamase β-Lactams
- Keyword (es)
- Actividad biológica Animal Antibacteriano Antibiótico Artículo síntesis Asociación medicamentosa Ceftazidima Química Cefalosporina derivado Eficacia tratamiento Ensayo clínico Hombre Indicación Mecanismo acción Farmacocinética Resistencia tratamiento Toxicidad Avibactam Enzima Hydrolases Inhibidor enzima β-Lactamase β-Lactams
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S02 Antibacterial agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27129876
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s40265-013-0013-7 
https://dx.doi.org/10.1007/s40265-013-0013-7
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s40265-013-0013-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Drugs (Basel)\";s:9:\"\u0000*\u0000stitle\";s:13:\"Drugs (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"159\";s:8:\"\u0000*\u0000epage\";s:3:\"177\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-6667\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ZHANEL\";s:10:\"\u0000*\u0000aufirst\";s:8:\"George G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:21:\"LAWSON, Christopher D\";i:1;s:15:\"LYNCH, Joseph P\";i:2;s:18:\"KARLOWSKY, James A\";i:3;s:13:\"ADAM, Heather\";i:4;s:16:\"SCHWEIZER, Frank\";i:5;s:18:\"ZELENITSKY, Sheryl\";i:6;s:27:\"LAGACE-WIENS, Philippe R. S\";i:7;s:16:\"DENISUIK, Andrew\";i:8;s:17:\"RUBINSTEIN, Ethan\";i:9;s:13:\"GIN, Alfred S\";i:10;s:14:\"HOBAN, Daryl J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DRUGAY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:8:\"\u0000*\u0000place\";s:8:\"Auckland\";s:6:\"\u0000*\u0000pub\";s:18:\"Adis International\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"19\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s40265-013-0013-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Drugs (Basel)\";s:9:\"\u0000*\u0000stitle\";s:13:\"Drugs (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"159\";s:8:\"\u0000*\u0000epage\";s:3:\"177\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-6667\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ZHANEL\";s:10:\"\u0000*\u0000aufirst\";s:8:\"George G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:21:\"LAWSON, Christopher D\";i:1;s:15:\"LYNCH, Joseph P\";i:2;s:18:\"KARLOWSKY, James A\";i:3;s:13:\"ADAM, Heather\";i:4;s:16:\"SCHWEIZER, Frank\";i:5;s:18:\"ZELENITSKY, Sheryl\";i:6;s:27:\"LAGACE-WIENS, Philippe R. S\";i:7;s:16:\"DENISUIK, Andrew\";i:8;s:17:\"RUBINSTEIN, Ethan\";i:9;s:13:\"GIN, Alfred S\";i:10;s:14:\"HOBAN, Daryl J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DRUGAY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:8:\"\u0000*\u0000place\";s:8:\"Auckland\";s:6:\"\u0000*\u0000pub\";s:18:\"Adis International\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"19\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s40265-013-0013-7\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s40265-013-0013-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Drugs (Basel)\";s:9:\"\u0000*\u0000stitle\";s:13:\"Drugs (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"159\";s:8:\"\u0000*\u0000epage\";s:3:\"177\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-6667\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ZHANEL\";s:10:\"\u0000*\u0000aufirst\";s:8:\"George G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:21:\"LAWSON, Christopher D\";i:1;s:15:\"LYNCH, Joseph P\";i:2;s:18:\"KARLOWSKY, James A\";i:3;s:13:\"ADAM, Heather\";i:4;s:16:\"SCHWEIZER, Frank\";i:5;s:18:\"ZELENITSKY, Sheryl\";i:6;s:27:\"LAGACE-WIENS, Philippe R. S\";i:7;s:16:\"DENISUIK, Andrew\";i:8;s:17:\"RUBINSTEIN, Ethan\";i:9;s:13:\"GIN, Alfred S\";i:10;s:14:\"HOBAN, Daryl J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DRUGAY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:8:\"\u0000*\u0000place\";s:8:\"Auckland\";s:6:\"\u0000*\u0000pub\";s:18:\"Adis International\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"19\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s40265-013-0013-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Drugs (Basel)\";s:9:\"\u0000*\u0000stitle\";s:13:\"Drugs (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"159\";s:8:\"\u0000*\u0000epage\";s:3:\"177\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-6667\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ZHANEL\";s:10:\"\u0000*\u0000aufirst\";s:8:\"George G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:21:\"LAWSON, Christopher D\";i:1;s:15:\"LYNCH, Joseph P\";i:2;s:18:\"KARLOWSKY, James A\";i:3;s:13:\"ADAM, Heather\";i:4;s:16:\"SCHWEIZER, Frank\";i:5;s:18:\"ZELENITSKY, Sheryl\";i:6;s:27:\"LAGACE-WIENS, Philippe R. S\";i:7;s:16:\"DENISUIK, Andrew\";i:8;s:17:\"RUBINSTEIN, Ethan\";i:9;s:13:\"GIN, Alfred S\";i:10;s:14:\"HOBAN, Daryl J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DRUGAY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:8:\"\u0000*\u0000place\";s:8:\"Auckland\";s:6:\"\u0000*\u0000pub\";s:18:\"Adis International\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"19\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s40265-013-0013-7\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Drugs (Basel)\";s:9:\"\u0000*\u0000stitle\";s:13:\"Drugs (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"159\";s:8:\"\u0000*\u0000epage\";s:3:\"177\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-6667\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ZHANEL\";s:10:\"\u0000*\u0000aufirst\";s:8:\"George G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:21:\"LAWSON, Christopher D\";i:1;s:15:\"LYNCH, Joseph P\";i:2;s:18:\"KARLOWSKY, James A\";i:3;s:13:\"ADAM, Heather\";i:4;s:16:\"SCHWEIZER, Frank\";i:5;s:18:\"ZELENITSKY, Sheryl\";i:6;s:27:\"LAGACE-WIENS, Philippe R. S\";i:7;s:16:\"DENISUIK, Andrew\";i:8;s:17:\"RUBINSTEIN, Ethan\";i:9;s:13:\"GIN, Alfred S\";i:10;s:14:\"HOBAN, Daryl J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DRUGAY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:79:\"Ceftazidime-Avibactam: a Novel Cephalosporin\/\u03b2-lactamase Inhibitor Combination\";s:8:\"\u0000*\u0000place\";s:8:\"Auckland\";s:6:\"\u0000*\u0000pub\";s:18:\"Adis International\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"19\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
